Addressing an Evolving Drug Safety Landscape - Moving from passive to active pharmacovigilance

Preview:

Citation preview

•0%

20%

40%

60%

80%

100%

Manufacturersubmitted -Expedited

reports

Manufacturersubmitted -

Periodicreports

Direct reportsby HCPs &

Patients

Incompletereports

Completereports

2% 3% 1%

11%

15%

5%

32%

4% 6%

5%

9%

12%

12%

.

Recommended